SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAukett Swanke Regulatory News (AUK)

  • There is currently no data for AUK

Director/PDMR Shareholding

12 Apr 2011 09:26

RNS Number : 7448E
Aukett Fitzroy Robinson Group PLC
12 April 2011
 

Tuesday 12 April 2011

 

 

 

Aukett Fitzroy Robinson Group Plc

("the Company")

 

Grant of Options to a Director

 

 

 

 

On Monday 11 April 2011, Duncan Harper, a director of the Company, was granted options over 500,000 ordinary shares in the Company. These options have an exercise price of 5 pence, a vesting period of two years from grant, and expire six years after grant.

 

At the same time the Company also granted options over a further 500,000 ordinary shares each to Suzette Vela and Luke Schuberth, two senior employees of the Company, on the same terms.

 

 

 

Enquiries

 

Aukett Fitzroy Robinson - 020 7636 8033

Nicholas Thompson, Chief Executive Officer

Duncan Harper, Group Finance Director

 

FinnCap - 020 7600 1658

Corporate Finance Clive Carver / Rose Herbert

Corporate Broking Simon Starr / Stephen Norcross

 

Hermes Financial PR

Chris Steele - 07979 604687

Trevor Phillips - 07889 153628

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGIGDSLDBBGBD
Date   Source Headline
3rd Mar 202510:30 amRNSChange of Name
14th Jan 202511:15 amRNSHolding(s) in Company
5th Dec 20241:08 pmRNSDirector and PCA Dealings
28th Nov 20247:00 amRNS-RNotice of presence at Anticipate London 2024
14th Nov 20247:00 amRNSChange of Auditor
18th Sep 20247:00 amRNSProperty disposal completion & Corporate update
20th Aug 20245:15 pmRNSHolding(s) in Company
20th Aug 20241:15 pmRNSHolding(s) in Company
6th Aug 20245:30 pmRNSHolding(s) in Company
1st Aug 202410:00 amRNSDirector Dealing
17th Jul 20247:00 amRNSHolding(s) in Company
15th Jul 20241:00 pmRNSAIM Rule 17 - Schedule 2(g) Update
5th Jul 20244:25 pmRNSProperty Disposal Update
28th Jun 20247:01 amRNSWarrant Exercise
28th Jun 20247:00 amRNSInterim Results
24th Jun 20247:00 amRNSProperty Disposal
4th Jun 202412:45 pmRNSSmart Buildings software contract win
29th May 20242:15 pmRNSIssue of Equity
9th May 20247:00 amRNSIssue of Warrants & Director/PDMR Notifications
26th Apr 20243:15 pmRNSResult of Annual General Meeting
26th Apr 20247:55 amRNSAGM Trading Statement
4th Apr 20247:00 amRNSSubscription Update & Director/PDMR Notifications
28th Mar 202411:52 amRNSHolding(s) in Company
28th Mar 20247:00 amRNSFinal Results and Notice of AGM
27th Mar 202412:04 pmRNSHolding(s) in Company
27th Mar 202412:03 pmRNSHolding(s) in Company
21st Mar 20247:00 amRNSAcquisition, Subscription and Notice of Results
19th Feb 20247:00 amRNSArtificial Intelligence Consortium
14th Feb 202410:40 amRNSHolding(s) in Company
2nd Feb 20247:00 amRNSCommercial Update
4th Jan 20247:00 amRNSHolding(s) in Company
27th Dec 20237:00 amRNSLaunch of Employee Share Purchase Plans
17th Nov 20232:32 pmRNSHolding(s) in Company
14th Nov 20239:02 amRNSHolding(s) in Company
18th Oct 20237:00 amRNSAcquisition of TR Control Solutions Limited
10th Oct 202311:15 amRNSHolding(s) in Company
5th Oct 202312:01 pmRNSProperty marketed for sale
17th Jul 20237:00 amRNSAcquisition of Anders+Kern U.K. Limited
27th Jun 20237:05 amRNSAppointment of Chief Operating Officer
27th Jun 20237:00 amRNSInterim Results
27th Apr 20231:20 pmRNSHolding(s) in Company
24th Apr 20237:00 amRNSAppointment of Non-Executive Director
21st Apr 202311:45 amRNSResult of AGM and Board Changes
5th Apr 20233:15 pmRNSPosting of Notice of AGM and Annual Report
4th Apr 20237:00 amRNSDisposal of Live Events Business
28th Mar 20237:00 amRNSResults for the year ended 30 September 2022
21st Mar 20237:00 amRNSResult of GM, Board Change, Acquisition Completion
2nd Mar 20237:00 amRNSProposed Acquisition, Rule 9 Waiver and GM Notice
1st Feb 20234:53 pmRNSChange of Adviser
30th Jan 20234:37 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.